Pfizer 2026 rev hike

Pfizer raises 2026 forecasts as Eliquis, cancer drugs drive Q3 beat

Pfizer raised its 2026 revenue forecast to $62–$64 billion after Q3 earnings beat expectations driven by Eliquis and oncology products. Strategic acquisitions and cost cuts aim to sustain growth amid